Characteristics | HID | MSD | p |
---|---|---|---|
No. of patients | 119 | 132 | – |
Median age, years (range) | 28 (14–54) | 33 (16–56) | .127 |
Sex, no. (%) | Â | Â | .448 |
 Male/female | 65 (54.6)/54 (45.4) | 65 (49.2)/67 (50.8) |  |
Underlying diseases, (%) | Â | Â | .731 |
 AML | 54 (45.4) | 57 (43.2) |  |
 ALL | 55 (46.2) | 60 (45.4) |  |
 ALAL | 10 (8.4) | 15 (11.4) |  |
Disease stage at transplants, (%) | Â | Â | .447 |
 Primary induction failure | 58 (48.7) | 57 (43.2) |  |
 Relapse refractory | 61 (51.3) | 75 (56.8) |  |
WBC count at diagnosis, n (%) | Â | Â | .615 |
 ≥ 30,000 per mm3 | 57 (47.9) | 59 (44.7) |  |
 < 30,000 per mm3 | 62 (52.1) | 73 (55.3) |  |
Median BM blasts before conditioning (range) | 33% (7.0–96.0%) | 31% (8.0–98.0%) | .602 |
Genetics, (%) | Â | Â | .527 |
 Poor | 65 (54.6) | 66 (50.0) |  |
 Intermediate | 34 (28.6) | 45 (34.1) |  |
 Favorable | 5 (4.2) | 8 (6.1) |  |
 Unknown | 15 (12.6) | 13 (9.8) |  |
Graft no. (%) | Â | Â | - |
 BM + PBSC | 119 (100) | 3 (2.3) |  |
 PBSC | 0 (0) | 129 (97.7) |  |
Median MNCs, 108/kg (range) | 7.36 (3.76–12.80) | 7.80 (3.52–13.16) | .136 |
MedianCD34 + count, 106/kg (range) | 5.65 (1.15–15.16) | 5.41 (0.98–16.46) | .471 |
Follow-up time in survivors from transplant, median (range), mouth | 43.4 (20.5–71.5) | 41.6 (18.2–72.7) | .814 |